Polyvalent recombinant antigens: a new vaccine strategy

Area of Science:

• Biotechnology
• Immunology
• Vaccine Development

Background:

• Recombinant DNA technology enables production of subunit vaccines from infectious agents.
• Many subunit vaccines exhibit low immunogenicity due to poor antigen presentation.
• Improved antigen presentation is crucial for effective vaccine design.

Purpose of the Study:

• To explore novel recombinant DNA strategies for enhancing antigen production and presentation.
• To investigate the potential of yeast Ty element-derived carrier proteins for vaccine development.
• To assess the immunogenicity of hybrid virus-like particles (VLPs) displaying viral antigens.

Main Methods:

• Construction of hybrid genes linking yeast Ty element carrier proteins with viral antigens.
• Expression of fusion proteins in yeast, leading to self-assembly into VLPs.
• Evaluation of the immunogenicity of these hybrid Ty-VLPs in preclinical models.
• Utilizing carrier proteins from hepatitis B and polio viruses for polyvalent antigen production.

Main Results:

• Fusion proteins self-assembled into 60 nm virus-like particles (VLPs) in yeast.
• These hybrid Ty-VLPs effectively displayed viral antigens on their surface.
• The hybrid Ty-VLPs demonstrated strong immunogenicity, eliciting robust immune responses.
• Effective immune responses were observed even without the use of adjuvants.

Conclusions:

• Hybrid Ty-VLPs represent a promising platform for developing potent subunit vaccines.
• Yeast-derived VLPs enhance antigen presentation, overcoming limitations of traditional subunit vaccines.
• This approach offers a versatile strategy for producing multivalent particulate antigens.